Eddit

Version vom 31. Mai 2020, 09:32 Uhr

• Further reading

• Unproven ideas
• Reviews on covid19 disease

32202343 ä. Systematic review of COVID?19 in children shows milder cases and a better prognosis than adults
32196678 ä. Eleven faces of coronavirus disease 2019

• Clinical guidelines and advice

32279352 2020. Blood and blood product use during COVID-19 infection
32223716 2020. Diagnosis and Management of COVID-19 Disease
32221973 2020. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice
32189015 2020. "Coronavirus disease 2019" (COVID-19): update fur Anasthesisten und Intensivmediziner Marz 2020

• Respiration mgmt

32319081 2020. Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?

32341294 2020. Toward Precision Delivery of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019 Cardiorespiratory Failure
32317557 2020. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients

• Diagnosis (Laboratory)

32293905 2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients

• Diagnosis (Lung CT, Sonography)

32275766 2020. Point-of-care lung ultrasound in patients with COVID-19 - a narrative review
32298464 2020. Whole body point-care ultrasound for COVID-19: a multi-system approach to a multi-system disease
32357307 2020. Radiographic examination of the chest and COVID-19

• Diagnosis (other modalities)

• Structure of covid19

32348474 2020. Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle

• Target binding and uptake

32369402 2020. ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2)

• Cytopathic effects

• Secretion and shedding

• Innate sensing

• Immunology

• Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome

• Pathobiology

32379417 ä. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age

• Disease Models

• Similar diseases and pathomechanisms

32348692 2020. COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids

• Early symptoms

• Systemic disease, any manifestations
• Co-Infection

32173883 ä. COVID?19 and mycoplasma pneumoniae coinfection
32314699 2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic

• ARDS

• Pulmonary embolism, coagulation

• Hematology

• Heart

32255359 2020. Clinical utility of cardiac troponin measurement in COVID-19 infection

• Neurology, ophthalmology, orl

32327427 2020. Myositis as a manifestation of SARS-CoV-2

• Dermatology

• Gastroenterology, hepatology

32374032 2020. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors

• Kidney, urology

32376320 ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract
32320102 ä. Hydatidiform mole in the era of COVID?19 pandemic Is there an association?
32266828 2020. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)

• Risk and special populations

32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
32241792 2020. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
32354772 2020. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
32332075 2020. Patients with lupus are not protected from COVID-19
32332072 2020. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
32295789 2020. Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
32327426 2020. SLE patients are not immune to covid-19: importance of sending the right message across
32295787 2020. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
32321720 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
32312768 2020. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia

• The morbid survivor

32364491 ä. Are COVID-19 survivors at increased risk for suicide?
32282359 2020. Rehabilitation After Critical Illness in People With COVID-19 Infection

• Case reports

32277694 2020. Case Report: Death Due to Novel Coronavirus Disease (COVID-19) in Three Brothers
32375200 2020. Pneumomediastinum following intubation in COVID-19 patients: a case series
32304394 2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report

• Case series

32255382 2020. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China

• Registries

• Trials

• Candidate Compounds Covid19

32329159 2020. Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach
32376597 2020. Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
32345616 2020. Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
32304395 2020. COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support

32380318 ä. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection
32380316 ä. Convalescent plasma in Covid-19: Possible mechanisms of action
32380315 ä. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
32376396 ä. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
32376395 ä. SARS-CoV-2 infection among patients with systemic autoimmune diseases

32376403 ä. Imatinib might constitute a treatment option for lung involvement in COVID-19

32376398 ä. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
32361195 ä. SARS-CoV-2 infection complicated by inflammatory syndrome Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
32304139 ä. Progress and Concept for COVID?19 Vaccine Development
32213152 2020. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
32299796 2020. Antirheumatic agents in covid-19: is IL-6 the right target?

32366720 2020. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs

• Other routes of infection

32189463 ä. The possibility of COVID?19 transmission from eye to nose
32189460 ä. There may be virus in conjunctival secretion of patients with COVID?19

• Biophysics of aerosols

• Passive protective equipment

32352852 2020. Hydrocolloid dressing strip over bridge of nose to relieve pain and pressure from Filtered Face Piece (FFP) masks during the coronavirus (COVID-19) pandemic

• Running your hospital

32311772 2020. Intubation boxes for managing the airway in patients with COVID-19

32324055 2020. A safe method to evacuate pneumoperitoneum during laparoscopic surgery in suspected COVID-19 patients
32380058 ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership

32345617 2020. Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey
32345619 2020. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic
32219857 ä. Advice regarding COVID?19 and use of immunomodulators, in patients with severe dermatological diseases
32376399 ä. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion

• Mental aspects of health professionals

• Socio-psychiatric aspects of the status hygienicus

• Avoiding clinical medicine in other diseases

• Occupational medicine, workplace security and status hygienicus

• Economic aspects of the status hygienicus
• global famine

• Educational aspects of the status hygienicus

• Host, vector, one health, atmospheric aspects

32196426 2020. Seasonality of Respiratory Viral Infections

• Origin of Covid19

• Epidemiology

32298494 2020. The role of children in the transmission of mild SARS-CoV-2 infection
32369541 ä. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review
32267964 2020. Infection control in non-clinical areas during the COVID-19 pandemic

• Remission, recurrence and persistence

32366742 ä. Prolonged Viral RNA Shedding Duration in COVID-19
32342849 2020. Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19)

• Failure of executive measures

32324421 2020. Raids on Immigrant Communities During the Pandemic Threaten the Country s Public Health

• Failure of politics and public health guidance

32358933 2020. Lessons from the USA Delayed Response to the COVID-19 Pandemic

• Political abuse of Covid19

32227594 ä. Social media for rapid knowledge dissemination: early experience from the COVID?19 pandemic

• Lost people

• Lost civilization

• History of covid19 exploration

• misc.
• Research tools

• PrePrint scene
• from the ads
• Current state of coviki.org